Azaya Therapeutics, Inc. Patents Nanotherapy Breakthrough

Published: Mar 12, 2007

SAN ANTONIO--(BUSINESS WIRE)--Azaya Therapeutics, Inc., a company developing technology for targeted, safer and more effective chemotherapy drugs, has been granted a patent from the U.S. Patent and Trademark Office for Azaya’s novel PSL nanotechnology platform. The PSL technology allows for the consistent loading, sizing and stabilizing of active drugs into targeted nanoparticles.

Back to news